Page 1 of Clinical Trials for LUPRON, 198 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Last Updated: February 29, 2012
Condition(s): Lupus Erythematosus, Systemic; Systemic Vasculitis; Isolated Angiitis of Central Nervous System; Lung Disease With Systemic Sclerosis; Lung Disease Interstitial Diffuse
2
Completed
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Last Updated: October 25, 2011
Condition(s): Puberty, Precocious
3
Completed
A Study of Leuprolide to Treat Prostate Cancer
Last Updated: July 15, 2011
Condition(s): Prostate Cancer
4
Active, not recruiting
Safety Extension Study Of Lupron Depot In The Treatment Of Central Precocious Puberty
Last Updated: April 9, 2012
Condition(s): Puberty, Precocious
5
Completed
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Last Updated: April 8, 2011
Condition(s): Puberty, Precocious
6
Active, not recruiting
Melanoma Vaccine With Peptides and Leuprolide
Last Updated: October 17, 2011
Condition(s): Melanoma
7
Completed
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
Last Updated: January 25, 2012
Condition(s): Prostatic Neoplasms
8
Recruiting
Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Last Updated: March 27, 2012
Condition(s): Acute Lymphocytic Leukemia; Acute Myelogenous Leukemia; Myelodysplastic Syndrome RAEB 1
9
Active, not recruiting
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
Last Updated: February 10, 2012
Condition(s): Endometriosis; Dysmenorrhea; Dyspareunia
10
Completed
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
Last Updated: February 22, 2012
Condition(s): Prostatic Neoplasm
11
Suspended
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
Last Updated: March 7, 2012
Condition(s): Infertility
12
Recruiting
Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)
Last Updated: October 26, 2010
Condition(s): Healthy
13
Active, not recruiting
Neoadjuvant Abiraterone Acetate Plus Leuprolide Acetate in Men With Localized High Risk Prostate Cancer
Last Updated: July 26, 2011
Condition(s): Prostate Cancer
14
Completed
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
Last Updated: October 19, 2005
Condition(s): Cancer of Prostate
15
Completed
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Last Updated: January 12, 2012
Condition(s): Advanced Prostate Cancer; Lower Urinary Tract Symptoms
16
Completed
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
Last Updated: February 13, 2008
Condition(s): Endometriosis; Infertility
17
Active, not recruiting
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
Last Updated: January 18, 2012
Condition(s): Prostate Cancer
18
Active, not recruiting
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
Last Updated: April 16, 2012
Condition(s): Amenorrhea; Premature Ovarian Failure; Ovarian Function Insufficiency
19
Recruiting
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Last Updated: March 8, 2012
Condition(s): Prostate Cancer
20
Active, not recruiting
Benefit Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.
Last Updated: September 27, 2011
Condition(s): Metastases

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=LUPRON

Page 1 of Clinical Trials for LUPRON, 198 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About